Researchers at the School of Medicine have discovered clues to a particularly deadly form of rejection that can follow lung transplantation. Called antibody-mediated rejection, the condition remains impervious to available treatments and difficult to diagnose. The researchers have identified, in mice, a process that may prevent the condition and lead to possible therapies to treat it.
The Trump Administration released a proposed rule Jan. 31 that could alter the way many drugs are priced and paid for among Medicare and Medicaid plans. The proposed regulation would eliminate the regulatory safe harbor for rebates as they exist today, said Rachel Sachs, an expert on drug policy and pricing at Washington University in St. Louis.
Washington University’s Lifelong Learning Institute, which offers academic courses to learners 50 and over, has become the newest member of the national network of Osher Lifelong Learning Institutes, thanks to funding from the Bernard Osher Foundation.
The School of Engineering & Applied Science will be renamed the James McKelvey School of Engineering, in honor of trustee and distinguished alumnus Jim McKelvey Jr., who has made an unprecedented and transformative investment in the school.
Virtuoso pianist Nikolai Lugansky, praised for his “plush sound and plenty impetuosity” by The New York Times, will open Washington University’s third Great Artists Series Feb. 10 with works by Claude Debussy, Alexander Scriabin and Sergei Rachmaninoff.
“Eyes on the Prize,” which was created and produced by Washington University in St. Louis alumnus Henry Hampton, is the recipient of the 2019 Cinema Eye Legacy Award. University Libraries has preserved and made available original interviews for the documentary on the civil rights movement.
Prepare for a Super Bowl broadcast rife with social-issue and cause advertisements, because that’s what younger generations — read: consumers — want from a Sunday less about football than marketing, says Olin sports marketing expert Patrick Rishe.
The School of Medicine’s Steven Teitelbaum, MD, has been awarded the King Faisal International Prize in Medicine for his work on bone biology. The award recognizes scientists whose work has major benefits for humanity.
